Toshimasa Uemura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Toshimasa Uemura has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Junzo Tanaka
Department of Metallurgy and Ceramics Science, Tokyo Institute of Technology, S7-6, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan
7 shared publicationsHiroko Kojima
Nanosystem Research Institute (NRI), National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba Central-4, Tsukuba, Ibaraki 305-8562, Japan
6 shared publicationsYoshimi Ohyabu
AIST
6 shared publicationsJian Dong
Department of Orthopaedic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, Peoples' Republic of China
5 shared publicationsRena Matsumoto
Nanosystem Research Insutitute, AIST (National Institute of Advanced Industrial Science and Technology), Central 4, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8562, Japan
4 shared publicationsToshiyuki Ikoma
Department of Metallurgy and Ceramics Science, Tokyo Institute of Technology, S7-6, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan
4 shared publications
Latest Publications
- Open Access
- 11 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8496
Development of a Method for Scaffold-Free Elastic Cartilage Creation
Microtia is a congenital aplasia of the auricular cartilage. Conventionally, autologous costal cartilage grafts are collected and shaped for transplantation. However, in this method, excessive invasion occurs due to limitations in the costal cartilage collection. Due to deformation over time after transplantation of the shaped graft, problems with long-term morphological maintenance exist. Additionally, the lack of elasticity with costal cartilage grafts is worth mentioning, as costal cartilage is a type of hyaline cartilage. Medical plastic materials have been transplanted as alternatives to costal cartilage, but transplant rejection and deformation over time are inevitable. It is imperative to create tissues for transplantation using cells of biological origin. Hence, cartilage tissues were developed using a biodegradable scaffold material. However, such materials suffer from transplant rejection and biodegradation, causing the transplanted cartilage tissue to deform due to a lack of elasticity. To address this problem, we established a method for creating elastic cartilage tissue for transplantation with autologous cells without using scaffold materials. Chondrocyte progenitor cells were collected from perichondrial tissue of the ear cartilage. By using a multilayer culture and a three-dimensional rotating suspension culture vessel system, we succeeded in creating scaffold-free elastic cartilage from cartilage progenitor cells.
- 11 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8496
Open AccessDevelopment of a Method for Scaffold-Free Elastic Cartilage Creation
Microtia is a congenital aplasia of the auricular cartilage. Conventionally, autologous costal cartilage grafts are collected and shaped for transplantation. However, in this method, excessive invasion occurs due to limitations in the costal cartilage collection. Due to deformation over time after transplantation of the shaped graft, problems with long-term morphological maintenance exist. Additionally, the lack of elasticity with costal cartilage grafts is worth mentioning, as costal cartilage is a type of hyaline cartilage. Medical plastic materials have been transplanted as alternatives to costal cartilage, but transplant rejection and deformation over time are inevitable. It is imperative to create tissues for transplantation using cells of biological origin. Hence, cartilage tissues were developed using a biodegradable scaffold material. However, such materials suffer from transplant rejection and biodegradation, causing the transplanted cartilage tissue to deform due to a lack of elasticity. To address this problem, we established a method for creating elastic cartilage tissue for transplantation with autologous cells without using scaffold materials. Chondrocyte progenitor cells were collected from perichondrial tissue of the ear cartilage. By using a multilayer culture and a three-dimensional rotating suspension culture vessel system, we succeeded in creating scaffold-free elastic cartilage from cartilage progenitor cells.
- 1 August 2016
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 122 (2) , 219-225
Chondrogenic differentiation of human mesenchymal stem cells on fish scale collagen
- 1 August 2016
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 122 (2) , 219-225
Chondrogenic differentiation of human mesenchymal stem cells on fish scale collagen
- 22 July 2015
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 31 (1) , 31-41
Effect of enzymatically cross-linked tilapia scale collagen for osteoblastic differentiation of human mesenchymal stem cells
Type I collagen is an abundant component of bone tissue that has been used for bone tissue engineering using various cross-linking methods, including chemical agents, ultraviolet irradiation, and dehydrothermal treatment to enhance its physical properties. Collagens derived from mammalian animals are generally not used for implantable scaffolds owing to the potential for zoonotic infection. In addition, the toxicity of cross-linking agents and alteration of inherent properties after cross-linking have been issues. In this study, fish collagen derived from tilapia scales which are free from the risk of infection was employed to fabricate a three-dimensional porous scaffold. Tilapia scale collagen scaffolds were modified using microbial transglutaminase enzyme as a catalyst to preserve the inherent properties of collagen material. Human mesenchymal stem cells were incubated with various substitutes including tilapia scale collagen and porcine collagen–coated cell culture dishes with or without microbial transglutaminase, tilapia scale collagen, and porcine collagen scaffolds cross-linked by microbial transglutaminase. Differentiation of human mesenchymal stem cells was verified using alkaline phosphatase activity and osteocalcin assays. A remarkably enhanced expression of osteoblastic differentiation was observed selectively with tilapia scale collagen–coated dishes with/without microbial transglutaminase and tilapia scale collagen collagen scaffold cross-linked by microbial transglutaminase. Thus, the combination of tilapia scale collagen and the microbial transglutaminase cross-linking method will be useful for osteoblastic differentiation and bone tissue engineering.
- 22 July 2015
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 31 (1) , 31-41
Effect of enzymatically cross-linked tilapia scale collagen for osteoblastic differentiation of human mesenchymal stem cells
Type I collagen is an abundant component of bone tissue that has been used for bone tissue engineering using various cross-linking methods, including chemical agents, ultraviolet irradiation, and dehydrothermal treatment to enhance its physical properties. Collagens derived from mammalian animals are generally not used for implantable scaffolds owing to the potential for zoonotic infection. In addition, the toxicity of cross-linking agents and alteration of inherent properties after cross-linking have been issues. In this study, fish collagen derived from tilapia scales which are free from the risk of infection was employed to fabricate a three-dimensional porous scaffold. Tilapia scale collagen scaffolds were modified using microbial transglutaminase enzyme as a catalyst to preserve the inherent properties of collagen material. Human mesenchymal stem cells were incubated with various substitutes including tilapia scale collagen and porcine collagen–coated cell culture dishes with or without microbial transglutaminase, tilapia scale collagen, and porcine collagen scaffolds cross-linked by microbial transglutaminase. Differentiation of human mesenchymal stem cells was verified using alkaline phosphatase activity and osteocalcin assays. A remarkably enhanced expression of osteoblastic differentiation was observed selectively with tilapia scale collagen–coated dishes with/without microbial transglutaminase and tilapia scale collagen collagen scaffold cross-linked by microbial transglutaminase. Thus, the combination of tilapia scale collagen and the microbial transglutaminase cross-linking method will be useful for osteoblastic differentiation and bone tissue engineering.
- 25 December 2014
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (8) , 2531-2539
Rapid oriented fibril formation of fish scale collagen facilitates early osteoblastic differentiation of human mesenchymal stem cells
We studied the effect of fibril formation of fish scale collagen on the osteoblastic differentiation of human mesenchymal stem cells (hMSCs). We found that hMSCs adhered easily to tilapia scale collagen, which remarkably accelerated the early stage of osteoblastic differentiation in hMSCs during in vitro cell culture. Osteoblastic markers such as ALP activity, osteopontin, and bone morphogenetic protein 2 were markedly upregulated when the hMSCs were cultured on a tilapia collagen surface, especially in the early osteoblastic differentiation stage. We hypothesized that this phenomenon occurs due to specific fibril formation of tilapia collagen. Thus, we examined the time course of collagen fibril formation using high‐speed atomic force microscopy. Moreover, to elucidate the effect of the orientation of fibril formation on the differentiation of hMSCs, we measured ALP activity of hMSCs cultured on two types of tilapia scale collagen membranes with different degrees of fibril formation. The ALP activity in hMSCs cultured on a fibrous collagen membrane was significantly higher than on a non‐fibrous collagen membrane even before adding osteoblastic differentiation medium. These results showed that the degree of the fibril formation of tilapia collagen was essential for the osteoblastic differentiation of hMSCs. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2531–2539, 2015.
- 25 December 2014
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (8) , 2531-2539
Rapid oriented fibril formation of fish scale collagen facilitates early osteoblastic differentiation of human mesenchymal stem cells
We studied the effect of fibril formation of fish scale collagen on the osteoblastic differentiation of human mesenchymal stem cells (hMSCs). We found that hMSCs adhered easily to tilapia scale collagen, which remarkably accelerated the early stage of osteoblastic differentiation in hMSCs during in vitro cell culture. Osteoblastic markers such as ALP activity, osteopontin, and bone morphogenetic protein 2 were markedly upregulated when the hMSCs were cultured on a tilapia collagen surface, especially in the early osteoblastic differentiation stage. We hypothesized that this phenomenon occurs due to specific fibril formation of tilapia collagen. Thus, we examined the time course of collagen fibril formation using high‐speed atomic force microscopy. Moreover, to elucidate the effect of the orientation of fibril formation on the differentiation of hMSCs, we measured ALP activity of hMSCs cultured on two types of tilapia scale collagen membranes with different degrees of fibril formation. The ALP activity in hMSCs cultured on a fibrous collagen membrane was significantly higher than on a non‐fibrous collagen membrane even before adding osteoblastic differentiation medium. These results showed that the degree of the fibril formation of tilapia collagen was essential for the osteoblastic differentiation of hMSCs. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2531–2539, 2015.
- Open Access
- 1 January 2013
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 38 (1) , 109-121
Effect of Human Mesenchymal Stem Cells on the Growth of HepG2 and Hela Cells
Human mesenchymal stem cells (hMSCs) accumulate at carcinomas and have a great impact on cancer cell’s behavior. Here we demonstrated that hMSCs could display both the promotional and inhibitive effects on growth of HepG2 and Hela cells by using the conditioned media, indirect co-culture, and cell-to-cell co-culture. Cell growth was increased following the addition of lower proportion of hMSCs while decreased by treatment of higher proportion of hMSCs. We also established a novel noninvasive label way by using internalizing quantum dots (i-QDs) for study of cell-cell contact in the co-culture, which was effective and sensitive for both tracking and distinguishing different cells population without the disturbance of cells. Furthermore, we investigated the role of hMSCs in regulation of cell growth and showed that mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling pathways were involved in hMSC-mediated cell inhibition and proliferation. Our findings suggested that hMSCs regulated cancer cell function by providing a suitable environment, and the discovery from the study would provide some clues for development of effective strategy for hMSC-based cancer therapies.
- 1 January 2013
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 38 (1) , 109-121
Open AccessEffect of Human Mesenchymal Stem Cells on the Growth of HepG2 and Hela Cells
Human mesenchymal stem cells (hMSCs) accumulate at carcinomas and have a great impact on cancer cell’s behavior. Here we demonstrated that hMSCs could display both the promotional and inhibitive effects on growth of HepG2 and Hela cells by using the conditioned media, indirect co-culture, and cell-to-cell co-culture. Cell growth was increased following the addition of lower proportion of hMSCs while decreased by treatment of higher proportion of hMSCs. We also established a novel noninvasive label way by using internalizing quantum dots (i-QDs) for study of cell-cell contact in the co-culture, which was effective and sensitive for both tracking and distinguishing different cells population without the disturbance of cells. Furthermore, we investigated the role of hMSCs in regulation of cell growth and showed that mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling pathways were involved in hMSC-mediated cell inhibition and proliferation. Our findings suggested that hMSCs regulated cancer cell function by providing a suitable environment, and the discovery from the study would provide some clues for development of effective strategy for hMSC-based cancer therapies.
- 3 August 2012
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 101A (2) , 421-427
Engineered bone tissue associated with vascularization utilizing a rotating wall vessel bioreactor
Tissue‐engineered bone has attracted much attention as an alternative material for bone grafting; however, implantable bone tissue of an appropriate size and shape for clinical use has not yet been developed due to a lack of vascularization, which results in necrosis of the seeded cells in vivo. This is the first report of bone tissue engineering associated with vascularization by co‐culturing bone marrow mesenchymal stem cells (MSCs) with MSC‐derived endothelial cells (ECs) within a porous scaffold using a rotating wall vessel (RWV) bioreactor. MSC‐derived ECs were identified by immunofluorescence staining for von Willebrand factor (vWF) and by flow cytometry for CD31 expression. The tissue obtained was histochemically analyzed using toluidin blue, hematoxylin and eosin, anti‐osteopontin antibody, anti‐osteocalcin antibody, and tomato‐lectin stain. Results showed that bone tissue containing vascular‐like structures was generated. Three‐dimensional culture condition created by medium flow in the RWV vessel and the interaction of MSCs with MSC‐derived ECs might provide the cells an advantage in the construction of three‐dimensional bone tissue with blood vessels. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
- 3 August 2012
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 101A (2) , 421-427
Engineered bone tissue associated with vascularization utilizing a rotating wall vessel bioreactor
Tissue‐engineered bone has attracted much attention as an alternative material for bone grafting; however, implantable bone tissue of an appropriate size and shape for clinical use has not yet been developed due to a lack of vascularization, which results in necrosis of the seeded cells in vivo. This is the first report of bone tissue engineering associated with vascularization by co‐culturing bone marrow mesenchymal stem cells (MSCs) with MSC‐derived endothelial cells (ECs) within a porous scaffold using a rotating wall vessel (RWV) bioreactor. MSC‐derived ECs were identified by immunofluorescence staining for von Willebrand factor (vWF) and by flow cytometry for CD31 expression. The tissue obtained was histochemically analyzed using toluidin blue, hematoxylin and eosin, anti‐osteopontin antibody, anti‐osteocalcin antibody, and tomato‐lectin stain. Results showed that bone tissue containing vascular‐like structures was generated. Three‐dimensional culture condition created by medium flow in the RWV vessel and the interaction of MSCs with MSC‐derived ECs might provide the cells an advantage in the construction of three‐dimensional bone tissue with blood vessels. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
- 24 March 2012
- Published by Springer Nature
- p. 295-305
Cell Internalizing Anti-Mortalin Antibody for Generation of Illuminating MSCs for Long-Term In vitro and In vivo Tracking
- 24 March 2012
- Published by Springer Nature
- p. 295-305
Cell Internalizing Anti-Mortalin Antibody for Generation of Illuminating MSCs for Long-Term In vitro and In vivo Tracking
- 23 February 2012
- Published by Elsevier in Applied Surface Science
- Vol. 262, 60-63
Effects of implantation of three-dimensional engineered bone tissue with a vascular-like structure on repair of bone defects
- 23 February 2012
- Published by Elsevier in Applied Surface Science
- Vol. 262, 60-63
Effects of implantation of three-dimensional engineered bone tissue with a vascular-like structure on repair of bone defects
- 1 June 2011
- Published by Taylor & Francis in Science and Technology of Advanced Materials
- Vol. 12 (3) , 034405
Bone formation in vivo induced by Cbfa1-carrying adenoviral vectors released from a biodegradable porous β-tricalcium phosphate (β-TCP) material
Overexpression of Cbfa1 (a transcription factor indispensable for osteoblastic differentiation) is expected to induce the formation of bone directly and indirectly in vivo by accelerating osteoblastic differentiation. Adenoviral vectors carrying the cDNA of Cbfa1/til-1(Adv-Cbf1) were allowed to be adsorbed onto porous blocks of β-tricalcium phosphate (β-TCP), a biodegradable ceramic, which were then implanted subcutaneously and orthotopically into bone defects. The adenoviral vectors were released sustainingly by biodegradation, providing long-term expression of the genes. Results of the subcutaneous implantation of Adv-Cbfa1-adsorbed β-TCP/osteoprogenitor cells suggest that a larger amount of bone formed in the pores of the implant than in the control material. Regarding orthotopic implantation into bone defects, the released Adv-Cbfa1 accelerated regeneration in the cortical bone, whereas it induced bone resorption in the marrow cavity. A safer gene transfer using a smaller amount of the vector was achieved using biodegradable porous β-TCP as a carrier.
- 1 June 2011
- Published by Taylor & Francis in Science and Technology of Advanced Materials
- Vol. 12 (3) , 034405
Bone formation in vivo induced by Cbfa1-carrying adenoviral vectors released from a biodegradable porous β-tricalcium phosphate (β-TCP) material
Overexpression of Cbfa1 (a transcription factor indispensable for osteoblastic differentiation) is expected to induce the formation of bone directly and indirectly in vivo by accelerating osteoblastic differentiation. Adenoviral vectors carrying the cDNA of Cbfa1/til-1(Adv-Cbf1) were allowed to be adsorbed onto porous blocks of β-tricalcium phosphate (β-TCP), a biodegradable ceramic, which were then implanted subcutaneously and orthotopically into bone defects. The adenoviral vectors were released sustainingly by biodegradation, providing long-term expression of the genes. Results of the subcutaneous implantation of Adv-Cbfa1-adsorbed β-TCP/osteoprogenitor cells suggest that a larger amount of bone formed in the pores of the implant than in the control material. Regarding orthotopic implantation into bone defects, the released Adv-Cbfa1 accelerated regeneration in the cortical bone, whereas it induced bone resorption in the marrow cavity. A safer gene transfer using a smaller amount of the vector was achieved using biodegradable porous β-TCP as a carrier.